Publisher's Synopsis
For formulation scientists, presents case histories involving the use of therapeutic proteins and peptides that have been marketed or are under clinical testing. Each of the 11 chapters focuses primarily on a specific agent; examples include molecules of varying sizes, from 10 amino acids (Leuprolide) to 1,020 amino acids (Muromonab CD3), and those